WMJ-J-2, a novel hydroxamate-based histone deacetylase inhibitor, induced colorectal cancer cell death via LKB1-p53-miR320a-survivin/NRP1 signaling

被引:0
|
作者
Hsu, M. [1 ]
Chuang, Y. [2 ]
Hsu, Y. [3 ]
Huang, S. [1 ,4 ]
机构
[1] Taipei Med Univ, Sch Med, Dept Pharmacol, Coll Med, Taipei, Taiwan
[2] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan
[3] Landseed Hosp, Dept Surg, Taoyuan, Taiwan
[4] Taipei Med Univ Hosp, Dept Med Res, Taipei, Taiwan
来源
FEBS OPEN BIO | 2019年 / 9卷
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P-35-043
引用
收藏
页码:332 / 332
页数:1
相关论文
共 2 条
  • [1] A Novel Hydroxamate-Based Compound WMJ-J-09 Causes Head and Neck Squamous Cell Carcinoma Cell Death via LKB1-AMPK-p38MAPK-p63-Survivin Cascade
    Yen, Chia-Sheng
    Choy, Cheuk-Sing
    Huang, Wei-Jan
    Huang, Shiu-Wen
    Lai, Pin-Ye
    Yu, Meng-Chieh
    Shiue, Ching
    Hsu, Ya-Fen
    Hsu, Ming-Jen
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [2] WMJ-S-001, a novel aliphatic hydroxamate derivative, induces HCT116 colorectal cancer cell death through AMPK-p53-survivin signaling
    Huang, Y. -H.
    Huang, W. -J.
    Hsu, M. -J.
    FEBS JOURNAL, 2014, 281 : 516 - 516